Phase I study of an all-oral combination of vinorelbine (VRL) and cyclophosphamide (Ctx) as second line treatment in patients with metastatic breast cancer (MBC)

• 卷第38卷
• 印刷ISSN0959-8049
• 文件大小123.57KB
• 发表时间2002
• DOI10.1016/s0959-8049(02)80774-2